Chronic asthma results in cognitive dysfunction in immature mice

Exp Neurol. 2013 Sep:247:209-17. doi: 10.1016/j.expneurol.2013.04.008. Epub 2013 Apr 29.

Abstract

Asthma is the most common chronic childhood illness today. However, little attention is paid for the impacts of chronic asthma-induced hypoxia on cognitive function in children. The present study used immature mice to establish ovalbumin-induced chronic asthma model, and found that chronic asthma impaired learning and memory ability in Morris Water Maze test. Further study revealed that chronic asthma destroyed synaptic structure, impaired long-term potentiation (LTP) maintaining in the CA1 region of mouse hippocampal slices. We found that intermittent hypoxia during chronic asthma resulted in down-regulation of c-fos, Arc and neurogenesis, which was responsible for the impairment of learning and memory in immature mice. Moreover, our results showed that budesonide treatment alone was inadequate for attenuating chronic asthma-induced cognitive impairment. Therefore, our findings indicate that chronic asthma might result in cognitive dysfunction in children, and more attention should be paid for chronic asthma-induced brain damage in the clinical therapy.

Keywords: Asthma; BALF; Children; DG; G protein-coupled receptor 124; GAPDH; GPR124; HE; HFS; HIF-1α; IEG; LTP; Learning and memory; MWM; Morris Water Maze; PFA; Synaptic plasticity; VEGF; bronchial alveolar lavage fluid; dentate gyrus; fEPSP; field excitatory postsynaptic potential; glyceraldehyde-3-phosphate dehydrogenase; hematoxylin and eosin; high-frequency stimulation; hypoxia induced factor 1α; immediate early gene; long-term potentiation; paraformaldehyde; vascular endothelial growth factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Asthma / blood
  • Asthma / chemically induced
  • Asthma / complications*
  • Asthma / drug therapy
  • Bronchodilator Agents / therapeutic use
  • Budesonide / therapeutic use
  • Chronic Disease
  • Cognition Disorders / etiology*
  • Cognition Disorders / prevention & control
  • Cytoskeletal Proteins / metabolism
  • Developmental Disabilities / etiology*
  • Developmental Disabilities / prevention & control
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / physiology
  • Hippocampus / drug effects
  • Hippocampus / physiopathology
  • Hippocampus / ultrastructure
  • In Vitro Techniques
  • Ki-67 Antigen / metabolism
  • Lung / pathology
  • Lung / ultrastructure
  • Maze Learning / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Nerve Tissue Proteins / metabolism
  • Ovalbumin / adverse effects
  • Pneumonia / drug therapy
  • Pneumonia / etiology
  • Time Factors
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Bronchodilator Agents
  • Cytoskeletal Proteins
  • Ki-67 Antigen
  • Nerve Tissue Proteins
  • Vascular Endothelial Growth Factor A
  • activity regulated cytoskeletal-associated protein
  • Budesonide
  • Ovalbumin